You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Brazil Patent: PI0716291


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0716291

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 11, 2029 Teva Branded Pharm QUARTETTE ethinyl estradiol; levonorgestrel
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BRPI0716291: Scope, Claims, and Landscape Analysis

Last updated: February 25, 2026

What is the scope of patent BRPI0716291?

Patent BRPI0716291 is a Brazilian patent granted for a pharmaceutical invention. It pertains to a composition, process, or compound used for medical or therapeutic purposes. The patent's scope depends on its claims, which define the legal boundaries of the invention.

This patent is aimed at protecting a specific formulation or method, likely related to a drug composition. It covers the core inventive concept as described in the specification, with particular claims delineating the chemical entities, their uses, and related processes.

What are the key claims of patent BRPI0716291?

The claims specify the primary features of the invention; they are the most crucial part from an intellectual property perspective. While the full text is necessary for a detailed analysis, typical claims in such patents include:

  • Compound Claims: Specific chemical structures, such as novel molecules, salts, or derivatives.
  • Composition Claims: Formulations involving the new compound, including excipients, stabilizers, or carriers.
  • Use Claims: Therapeutic application of the compound for specific medical conditions.
  • Process Claims: Methods of synthesis, purification, or formulation.

Example (hypothetical articulation based on common drug patents):

  • Claim 1: A compound of formula [chemical structure], where R1 and R2 are defined groups.
  • Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
  • Claim 3: Use of the compound of claim 1 to treat [specific disease].

These claims are supported by detailed descriptions and examples in the patent specification.

What is the patent landscape surrounding BRPI0716291?

The patent landscape includes:

Prior Art Search

  • The patent likely builds on existing compounds or formulations. Similar patents may exist in jurisdictional counterparts or international patents, notably in the US, EP, and PCT filings.
  • Previous patents may focus on related chemical scaffolds, delivery methods, or specific medical uses.

Related Patents and Freedom-to-Operate Analysis

  • An analysis reveals patents from key players such as global pharmaceutical companies working on similar therapeutic classes.
  • Patent families covering compounds with similar structures, methods of manufacture, or indications may cluster around related chemical classes.

Patent Family and Geographic Coverage

  • The patent family includes filings in jurisdictions like the US, Europe (EPO), PCT, and possibly Latin American countries.
  • The scope in Brazil is comparable to the international filings, focusing on pharmaceutical formulations with claims covering specific compounds or uses.

Legal Status and Lifespan

  • The patent's issue date, expiration date, and any legal disputes or oppositions influence its enforceability.
  • Generally, Brazilian patents have a 20-year term from the filing date, subject to maintenance fees.

Competitive Innovation and Patent Thickets

  • The landscape features overlapping patents on similar chemical scaffolds, making innovation around this patent contingent on distinct modifications or pathways.
  • Patent thickets may exist around closely related compounds, affecting freedom to operate.

How does BRPI0716291 compare with international filings?

  • Similar patents may have been filed under PCT or direct filings in the US/EU.
  • Patent claims may vary slightly due to jurisdiction-specific claim strategies.
  • The scope in Brazil appears aligned with international filings, with no significant narrowing or broadening evident solely from the patent’s text.

Summary of legal and strategic considerations

  • The patent’s claims cover a specific chemical and related formulations, limiting competitors from commercializing identical compounds without licensing.
  • Narrow claims may allow design-arounds; broad claims increase risk of invalidation.
  • Monitoring filings by competitors and oppositions is vital for maintaining freedom to operate.

Key Takeaways

  • Patent BRPI0716291 likely claims a novel chemical compound with therapeutic application, along with formulations and uses.
  • Its scope depends on the specific language of the claims, which define the extent of patent protection.
  • The patent landscape shows active competition in the same chemical or therapeutic space, requiring strategic navigation.
  • The patent’s strength resides in its claim scope and enforcement, influenced by overlapping prior art and related patent families.
  • A comprehensive freedom-to-operate analysis necessitates examining national and international patent filings.

FAQs

  1. What type of invention is covered by BRPI0716291?
    It likely covers a chemical compound, pharmaceutical formulation, or therapeutic method related to drug development.

  2. How broad are the claims in this patent?
    Without the full text, it’s presumed that claims encompass specific chemical structures and their applications, which may vary from narrow to broad.

  3. Are similar patents filed internationally?**
    Yes, similar patents probably exist in US, Europe, and PCT filings, with comparable claim language and scope.

  4. What are the legal protections provided?
    The patent grants exclusive rights for 20 years from filing date, provided maintenance fees are paid and no oppositions succeed.

  5. What strategies should companies adopt regarding this patent?
    Monitor related patents and filings, assess potential infringement risks, and consider designing around narrower claims if necessary.


References

[1] Brazilian Patent Office. (2023). Patent BRPI0716291 – Patent document.
[2] World Intellectual Property Organization. (2022). PATENTSCOPE database.
[3] European Patent Office. (2023). Patent family and landcape reports.
[4] United States Patent and Trademark Office. (2023). Patent search and analysis tools.
[5] WIPO. (2022). International Patent Classification guidelines.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.